Pharmaceutical Press Releaseshttp://www.pharmiweb.com/Press Releases in the Pharmaceutical Industry. News, Jobs and Resources at PharmiWeb.comen-gb&#169; 1998 - 2012 PharmiWeb Solutions - All Rights ReservedSun, 4 Feb 2012 01:00:00 GMTPharmiWeb.comhttp://www.pharmiweb.com/images/logos/pweb_logo.gifhttp://www.Pharmiweb.com20http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53858Keller Rohrback L.L.P. Announces Investigation of Pfizer, Inc. Regarding the Lo/Ovral®-28 and Norgestrel Birth Control Pill Recall<strong>Keller Rohrback L.L.P. Announces Investigation of Pfizer, Inc. Regarding the Lo/Ovral®-28 and Norgestrel Birth Control Pill Recall</strong><br...<br />Keller Rohrback L.L.P.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53858Sun, 4 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53857SurModics to Webcast Annual Meeting on February 6<strong>SurModics to Webcast Annual Meeting on February 6</strong><br /> SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification a...<br />SurModics Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53857Sun, 4 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53856SurModics Announces Rescheduled Webcast for First Quarter 2012 Earnings Conference Call on February 6<strong>SurModics Announces Rescheduled Webcast for First Quarter 2012 Earnings Conference Call on February 6</strong><br /> SurModics, Inc. (Nasdaq: ...<br />SurModics Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53856Sun, 4 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53855PerkinElmer Highlights New Drug Discovery Research Solutions at the Society for Laboratory Automation and Screening (SLAS) 2012 Conference<strong>PerkinElmer Highlights New Drug Discovery Research Solutions at the Society for Laboratory Automation and Screening (SLAS) 2012 Conference</st...<br />PerkinElmer Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53855Sun, 4 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53854MSA Schedules Fourth Quarter Earnings Webcast<strong>MSA Schedules Fourth Quarter Earnings Webcast</strong><br />PR NewswirePITTSBURGH, Feb. 3, 2012PITTSBURGH, Feb. 3, 2012 /PRNewswire/ -- MSA (N...<br />MSAhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53854Sat, 3 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53853Design Concepts, Inc. Welcomes Seng Weiland, Strategic Account Manager<strong>Design Concepts, Inc. Welcomes Seng Weiland, Strategic Account Manager</strong><br /> Design Concepts, Inc., an award-winning innovation and d...<br />Design Concepts Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53853Sat, 3 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53851AXESS gives TOPRA Regulatory Affairs MSc lecture<strong>AXESS gives TOPRA Regulatory Affairs MSc lecture</strong><br />Paul Foster, Talent Acquisition Manager for AXESS, is passing on his expertise ...<br />AXESShttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53851Sat, 3 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53850Research and Markets: International Directory of Biotechnology Companies 2012: a must-have for anyone who needs to find contacts in the biotechnology sector worldwide<strong>Research and Markets: International Directory of Biotechnology Companies 2012: a must-have for anyone who needs to find contacts in the biotec...<br />Research and Marketshttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53850Sat, 3 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53849DiscoveRx Corporation Continues to Innovate with Solutions for Epigenetic Drug Discovery Programs<strong>DiscoveRx Corporation Continues to Innovate with Solutions for Epigenetic Drug Discovery Programs</strong><br /> DiscoveRx Corporation today a...<br />DiscoveRx Corporationhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53849Sat, 3 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53848Molecular Profiles Invests £9 million in New Facility To Increase Manufacturing Capabilities for Phase I and II Clinical Trials<strong>Molecular Profiles Invests £9 million in New Facility To Increase Manufacturing Capabilities for Phase I and II Clinical Trials</strong><br />...<br />Molecular Profiles http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53848Sat, 3 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53847Research and Markets: Global Drug Eluting (DES), Bare Metal (BMS) and Other Coronary Stents Market (2011 - 2016)<strong>Research and Markets: Global Drug Eluting (DES), Bare Metal (BMS) and Other Coronary Stents Market (2011 - 2016)</strong><br />Research and Ma...<br />Research and Marketshttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53847Sat, 3 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53846Bristol-Myers Squibb Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Inhibitex, Inc.<strong>Bristol-Myers Squibb Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Inhibitex, Inc.</strong><br /> Bristol-My...<br />Bristol-Myers Squibb Companyhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53846Sat, 3 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53845Natera’s Non-Invasive Prenatal Diagnostic to Detect Down Syndrome, Trisomy 13, Trisomy 18 and Certain Sex Chromosome Abnormalities in the First Trimester of Pregnancy<strong>Natera’s Non-Invasive Prenatal Diagnostic to Detect Down Syndrome, Trisomy 13, Trisomy 18 and Certain Sex Chromosome Abnormalities in the Firs...<br />Naterahttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53845Sat, 3 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53844Walgreens January Sales Decrease 2.3 Percent<strong>Walgreens January Sales Decrease 2.3 Percent</strong><br /> Walgreens (NYSE: WAG) (NASDAQ: WAG) had January sales of $5.80 billion, a decreas...<br />Walgreenshttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53844Sat, 3 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53843SAFE-BioPharma® Standard to be Highlighted at Molecular TriCon<strong>SAFE-BioPharma® Standard to be Highlighted at Molecular TriCon</strong><br /> The role of SAFE-BioPharma interoperable digital identities in a...<br />SAFE-BioPharmahttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53843Sat, 3 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53842Abiomed Reports Record Revenue of $32.2 Million and Earnings of $2.9 Million for Third Quarter of Fiscal 2012<strong>Abiomed Reports Record Revenue of $32.2 Million and Earnings of $2.9 Million for Third Quarter of Fiscal 2012</strong><br />Abiomed, Inc. (NA...<br />Abiomed Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53842Sat, 3 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53841Transgenomic Announces $22.0 Million Private Placement Financing<strong>Transgenomic Announces $22.0 Million Private Placement Financing</strong><br />Transgenomic, Inc. (OTCBB:TBIO) today announced that it has en...<br />Transgenomic Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53841Sat, 3 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53840Histogenics Corporation to Present at Canaccord Genuity Musculoskeletal Conference<strong>Histogenics Corporation to Present at Canaccord Genuity Musculoskeletal Conference</strong><br /> Histogenics Corporation, a privately held, r...<br />Histogenicshttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53840Sat, 3 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53839Incyte to Present at the Leerink Swann 2012 Global Healthcare Conference<strong>Incyte to Present at the Leerink Swann 2012 Global Healthcare Conference</strong><br /> Incyte Corporation (Nasdaq:INCY) announced today it wi...<br />Incyte Corporationhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53839Sat, 3 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53838Acorda Therapeutics Presents Preclinical Data Showing Dalfampridine Improves Motor Function in Chronic Stroke<strong>Acorda Therapeutics Presents Preclinical Data Showing Dalfampridine Improves Motor Function in Chronic Stroke</strong><br /> Acorda Therapeuti...<br />Acorda Therapeutics Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53838Sat, 3 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53837Michael Kaufmann of Cardinal Health Named as the Healthcare Businesswomen's Association's 2012 Honorable Mentor<strong>Michael Kaufmann of Cardinal Health Named as the Healthcare Businesswomen&apos;s Association&apos;s 2012 Honorable Mentor</strong><br />PR New...<br />HEALTHCARE BUSINESSWOMEN&apos;S ASSOCIATIONhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53837Sat, 3 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53836Research and Markets: Triple Analysis: Lymphoma, Apoptosis and Antibodies<strong>Research and Markets: Triple Analysis: Lymphoma, Apoptosis and Antibodies</strong><br />Research and Markets (http://www.researchandmarkets.co...<br />Research and Marketshttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53836Sat, 3 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53835Research and Markets: Triple Analysis: Breast Cancer, Prostate Cancer and Apoptosis<strong>Research and Markets: Triple Analysis: Breast Cancer, Prostate Cancer and Apoptosis</strong><br />Research and Markets (http://www.researchand...<br />Research and Marketshttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53835Sat, 3 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53834Dr. Reddy’s Q3 FY12 Financial Results<strong>Dr. Reddy’s Q3 FY12 Financial Results</strong><br /> Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced its unaudited consolidated fin...<br />Dr. Reddy’s Laboratories Ltd.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53834Sat, 3 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53833Cabozantinib Shows Encouraging Activity in Heavily Pretreated Patients With Advanced Renal Cell Carcinoma<strong>Cabozantinib Shows Encouraging Activity in Heavily Pretreated Patients With Advanced Renal Cell Carcinoma</strong><br /> Exelixis, Inc. (NASDA...<br />Exelixis Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53833Sat, 3 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53832RBCC: Biotech Industry on Major Upswing in 2012<strong>RBCC: Biotech Industry on Major Upswing in 2012</strong><br /> All signs point to emerging biotech company Rainbow Coral Corp. (OTCBB:RBCC) f...<br />Rainbow BioSciences LLChttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53832Sat, 3 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53831Merck KGaA and Threshold Announce Global Agreement to Co-Develop and Commercialize Phase III Hypoxia-Targeted Drug TH-302<strong>Merck KGaA and Threshold Announce Global Agreement to Co-Develop and Commercialize Phase III Hypoxia-Targeted Drug TH-302</strong><br />Phase ...<br />Merck Seronohttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53831Sat, 3 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53830Sirona Reports Fiscal 2012 First Quarter Results<strong>Sirona Reports Fiscal 2012 First Quarter Results</strong><br /> Sirona (Nasdaq: SIRO), the dental technology leader, today announced its fina...<br />Sirona Dental Systems Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53830Sat, 3 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53829Company Profile for JPT Peptide Technologies GmbH<strong>Company Profile for JPT Peptide Technologies GmbH</strong><br /> JPT Peptide Technologies is a DIN ISO 9001:2008 certified provider of innova...<br />JPT Peptide Technologieshttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53829Sat, 3 Feb 2012 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53828MannKind Receives Commitment from The Mann Group to Acquire 31,250,000 Shares of Common Stock<strong>MannKind Receives Commitment from The Mann Group to Acquire 31,250,000 Shares of Common Stock</strong><br />MannKind Corporation (Nasdaq: MNKD...<br />MannKind Corporationhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=53828Sat, 3 Feb 2012 01:00:00 GMT